The “Medical Bypass”: new drugs to strike obesity
Pharmaceutical Technology
NOVEMBER 30, 2022
NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. Results from this trial are scheduled to be released in October 2027, and may allow non-diabetic obese patients to have access to Mounjaro.
Let's personalize your content